Literature DB >> 24464963

Are autoantibodies to RNA-polymerase III to be incorporated in routine diagnostic laboratory algorithms for systemic autoimmune rheumatic diseases?

Jan Damoiseaux.   

Abstract

Entities:  

Keywords:  Adult Onset Still's Disease; Amyloidosis; Analgesics

Mesh：

Year:  2014        PMID： 24464963     DOI： 10.1136/annrheumdis-2014-205193

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  3 in total

1.  Mesenchymal stem cell therapy for refractory scleroderma: a report of 2 cases.

Authors:  Terek Wehbe; Majid Abi Saab; Nassim Abi Chahine; Talar Margossian
Journal:  Stem Cell Investig       Date:  2016-09-19

Review 2.  Anti-RNA polymerase III antibodies in patients with suspected and definite systemic sclerosis: Why and how to screen.

Authors:  Maria-Grazia Lazzaroni; Paolo Airò
Journal:  J Scleroderma Relat Disord       Date:  2018-07-13

3.  Autoantibodies in the disease criteria for systemic sclerosis: The need for specification for optimal application.

Authors:  Jan Damoiseaux; Judith Potjewijd; Ruben L Smeets; Carolien Bonroy
Journal:  J Transl Autoimmun       Date:  2022-01-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.